Médecins Sans Frontières calls for affordable access to critical TB drug bedaquiline

Médecins Sans Frontières to Johnson & Johnson: We need affordable and sustainable supply of bedaquiline.

On 17 September 2018, Médecins Sans Frontières sent an open letter to Johnson & Johnson urging the pharmaceutical corporation to take action so that countries can access an affordable and sustainable supply of the critical drug bedaquiline, used to treat multidrug-resistant TB.





Source: Médecins Sans Frontières

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Médecins Sans Frontières

Published: Sept. 18, 2018, 10:15 a.m.

Last updated: Sept. 24, 2018, 11:49 a.m.

Print Share